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1. Introduction 
The role of immuno-inflammatory responses in the cornea and ocular surface has 
continuously been evolving over the past decades and has been becoming the center stage 
for therapeutic approaches for many diseases. In fact, the relevance of inflammation as a 
significant component in the pathophysiology of most acute and chronic forms of corneal 
and ocular surface diseases (e.g., microbial keratitis, allergy, and dry eye syndrome) has 
become evident. Both local and systemic immunomodulation with anti-inflammatory 
agents have been used successfully in improving these conditions or bringing these 
conditions under control. Thus, understanding the cellular and molecular mechanisms by 
which the ocular surface participates in immuno-inflammatory disorders is crucial for a 
more rational clinical approach to treating these diseases. 
There are several unique anatomical and physiological features of the cornea and  
ocular surface as compared to other tissues in the body, which translate into specific 
mechanisms by which they are involved in both inciting and expressing immunity, as 
well as preventing unnecessary inflammation. There are a very large number of immune 
and inflammatory disorders that involve the cornea and ocular surface. Control of 
leukocyte entry and migration within the cornea and ocular surface is thus vital to 
regulate protective and pathological responses. While local control of pathogens is 
dependent on the ability of immune cells to access and operate within these sites, too 
much inflammation can be deleterious and lead to loss of vision. In this chapter, the 
current knowledge on the coordinated migratory events that regulate leukocyte 
trafficking in the cornea and ocular surface are discussed. The aim is to first provide an 
overview of the contribution of resident bone marrow (BM)-derived cells of the cornea 
and ocular surface. Second, the role of infiltrating leucocytes in some of the innate defense 
mechanisms will be discussed. Third, we will provide a summary of the mechanisms that 
dictate immune cell trafficking to the cornea and ocular surface in response to 
inflammation. Finally, we will discuss trafficking mechanisms of antigen presenting cells 
from the cornea and ocular surface to draining lymph nodes where the immune responses 
are initiated. 
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2. Role of leukocytes in disease 
2.1 Overview of resident leukocytes 
The cornea and ocular surface have constant and direct contact with the external world. This 
necessitates a powerful and intrinsic immune surveillance system involved in their natural 
defense. Resident ocular tissue elements together with circulating bone marrow-derived 
cells are important components of this system, delicately balancing defense and tolerance 
under steady sate conditions. The ocular surface consists of three distinct anatomical 
regions: the cornea, limbus, and the conjunctiva. These regions function both in concert and 
independently against microbial, immunogenic and traumatic insults.  
Antigen presenting cells (APCs) and in particular dendritic cells (DCs) orchestrate the 
immune response through their capacity to capture, process and subsequently present 
antigens. APCs serve as the principal immune sentinels to the foreign world. They can be 
divided into ‘professional’ and ‘nonprofessional’ types. While the latter are found among 
nonlymphoid tissues (e.g., vascular endothelial or some tissue epithelial cells), professional 
APC are BM-derived, and form an integral part of the immune system. Professional APCs 
include DCs (including epithelial Langerhans cells; LCs), macrophages, and B cells, 
although DCs are the most potent APCs. Expression of major histocompatibility class II 
(MHC-II) antigens on DCs, whose primary function is to distinguish between self and non-
self, plays an integral role in antigen recognition and presentation. DCs have a dual function 
as key regulators of T cell immunity and tolerance induction to both self and foreign 
antigens. Precursor and progenitor DCs constitutively repopulate normal tissues from the 
bloodstream, and are recruited in elevated numbers to sites of inflammation. A second type 
of DC precursors is constituted by peripheral blood monocytes that are recruited during an 
inflammation.  
DCs originate from bone marrow hematopoietic stem cells. (Traver et al., 2000; Wu et al., 
2001) DC progenitors are not restricted to the BM and can be found in multiple locations. 
These progenitors can differentiate into DC upon challenge in peripheral tissues. Fully 
differentiated DC are found in healthy tissues as immunologically immature cells, being 
able to sample foreign antigens, but not able activate T cells. Although rare in numbers in 
the circulation, one fully mature DC is capable to interact with ten thousand T cells per 
day.(O'Keeffe et al., 2003) DC consist of several distinct populations that can be 
differentiated by surface and intracellular phenotypic markers, immunological function, and 
anatomic location. Irrespective of their phenotype and immunological role, DC exert their 
activity in the eye remote from their place of origin, where they utilize their advanced 
migratory skills for navigation. Currently, factors leading to the development from 
precursor DC to differentiated mature DC are still largely unknown. It has been shown that 
depending on the environmental cues, different forms of DC may be generated.(Naik et al., 
2006) Further, while in lymphoid as well as in some non-lymphoid organs,(Kabashima et al., 
2005; Merad et al., 2002) DC have been shown to proliferate locally, it is yet unclear whether 
resident corneal DC have the same proliferative potential, or are alternatively replenished 
through circulating DC. The diverse functions of DC in immune regulation depend on the 
diversity of DC subsets and lineages and on the functional plasticity of DCs at their 
immature stage.  
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Over the last several decades, the search for corneal APC, largely reliant on their presumed 
and universal MHC-II expression, had led to the dogma that APC are essentially absent in 
the central corneal. This absence of corneal APC was assumed to be a critical component of 
corneal immune privilege. However, this paradigm has now shifted with the demonstration 
of a diverse population of resident APC over the last years.(Hamrah et al., 2003a; Hamrah et 
al., 2003b, c) Dendritic cells, the sentinels of the immune system, were recently discovered to 
reside not only in the peripheral cornea, but also in the centreal cornea (Fig 1).(Hamrah et 
al., 2003c; Hamrah et al., 2002b; Liu et al., 2002) While a large number of DC are MHC class 
II+ in the periphery, a large population of MHC class II-negative immature/precursor DC are 
present both in the central  epithelium and stroma.(Hamrah et al., 2003c; Hamrah et al., 
2002b) Immature DC do neither express major histocompatibility complex (MHC)-II nor 
costimulatory molecules unless they are incited by cytokines. Thus, in contrast to other 
organs, where terminally differentiated populations of resident DC and/or macrophages 
outnumber colonizing precursors, large numbers of DCs within the cornea remain in an 
undifferentiated state.  
 
Fig. 1. Dendritic Cell in central corneal epithelium in CD11c-Yellow fluorescent protein 
(YFP) transgenic mouse 
The constitutive presence of these DCs in the cornea focuses now attention on the cornea as a 
participant in immune and inflammatory responses, rather than the cornea being essentially a 
collagenous tissue that simply responds to the activity of infiltrating cells. Other immune cells 
that populate the cornea and ocular surface are T cells, B cells, macrophages, plasma cells, and 
neutrophils (PMN). Further, macrophages and neutrophils together with natural killer (NK) 
cells, initially constitute the primary innate immune response, while DCs, T cells and B cells 
largely play a role in the secondary, adaptive response.(Janeway C, 2004) While the primary 
innate immune response is non-specific, rapid, and lacks memory, the secondary adaptive 
immune response is slower, but highly specific. Further, T and B cell responses maintain 
immunological memory, such that any following encounters with the same antigen will lead 
to rapid and robust immune responses.  
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2.2 Microbial keratitis 
2.2.1 Herpes simplex virus type-1 (HSV-1)  
HSV-1, is a member of the α-herpesviridae family of double-stranded DNA (dsDNA) 
viruses.(Shukla & Spear, 2001) HSV-1 infections are prevalent both in the developed and 
developing countries with a higher and earlier onset of seroconversion in population groups 
of lower socioeconomic status.(Whitley & Roizman, 2001) 60% to 90% of the global adult 
population is infected with this pathogen, with a remarkably high prevalence of 
approximately 90% in the United States.(Carr et al., 2001; Whitley & Roizman, 2001) The two 
main forms of ocular HSV-1 infections are epithelial keratitis, and immune stromal 
keratitis.(Thomas, J. & Rouse, 1997) In the West, HSV-1 is also the leading cause of blindness 
secondary to recurrent infection, corneal stromal inflammation (herpes stromal keratitis; 
HSK), stromal thinning, neovascularisation and scarring.(Dana, M. R. et al., 2000)  
The ocular surface, through several means, is able retard host invasion by external 
pathogens. The tear film which forms the outermost layer of the ocular surface presents 
the first barrier to viral invasion.(Farris, 1998) Some of the anti-viral factors in the tear film 
include, but are not limited to, tear film proteins such as lysozyme, immunoglobulin A 
(IgA), lactate dehydrogenase (LDH), complement proteins, amylase, peroxidase, as well 
as interferons alpha (IFNα) and beta (IFNȕ). (Babu et al., 1995; Chatterjee et al., 1984; Chen 
et al., 1994) Since herpes viruses rely on replication and dissemination in metabolically 
active cells (Schang et al., 1998; Schang et al., 2000), the terminally differentiated outer 
layers of the corneal epithelium act as both a physical and metabolic barrier against viral 
entry. In the event of a breach in the integrity of the corneal epithelium, the virion 
attaches to epithelial cells via interaction of its surface glycoproteins with cognate 
receptors, (Campadelli-Fiume et al., 2007; Shukla et al., 1999; Spear, 2004) leading to either 
attachment, surfing and fusion of the virion envelope to the host cell plasma membrane, 
or, via endocytosis of the nucleocapsid into the host cell cytoplasm. Having intercepted 
the barriers to entry, HSV-1 inhibits its host’s programmed cell death, assembles its 
immune-defying, host-crippling machinery to invade, replicate and infect the cornea, 
nerves and eventually the trigeminal ganglion where the virus maintains lifelong latency, 
leading to recurrent infections and potentially irreversible damage to the corneal 
tissue.(Akhtar & Shukla, 2009; Whitley & Roizman, 2001) Transmission may occur 
through cell lysis and shedding of viral progeny or cell-to-cell spread of the virion. Once 
the host corneal epithelial layers are penetrated, HSV replicates in the corneal epithelial 
cells. Following host infection, the outcome of viral latency or resolution has been shown 
to be dependent on the initial viral load.(Kintner & Brandt, 1995). 
Cytokines are low molecular weight proteins produced by various resident corneal cells 
such as epithelial cells, stromal cells, and APCs.(Torres & Kijlstra, 2001) They are responsible 
for recruiting inflammatory and immune cells via cell-to-cell signalling through autocrine, 
paracrine and endocrine pathways, thus promoting tissue damage.(Balkwill & Burke, 1989) 
As the disease course changes, expression profiles of cytokines follow suit. During the early 
phase of HSK, the cornea expresses interleukin (IL)-1α, interferon (IFN)-γ and IL-2, whereas 
IL-4 is expressed later, indicating that the Th1 T cell response is required for induction of 
HSK. (Babu et al., 1995; Niemialtowski & Rouse, 1992b) (Heiligenhaus et al., 1999) While  
IL-2 may be responsible for incurring destructive effects on the stroma, IL-2 knockout mice 
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are more prone to severe HSV infection, which is ameliorated by providing recombinant IL-
2 treatment, hence indicating that the Th1 T cell response not only plays a role in tissue 
destruction, but also plays a protective role against HSV-1 invasion.(Ghiasi et al., 1999) 
Paradoxically, IFN-γ has also been implicated in the clearance of virus from the cells thus 
reducing latency, (Bouley et al., 1995; Smith et al., 1994) (Hendricks et al., 1991) yet driving 
immunopathogenesis as exemplified by the reduction in HSK severity following 
neutralisation of IFN-γ titres beforehand. (Hendricks et al., 1992b; Niemialtowski & Rouse, 
1992a, b) Among the array of cytokines produced, IL-1 is particularly pertinent to corneal 
melting by induction of LC migration into the cornea thereby priming the tissue for further 
destruction. In order to combat the effects of IL-1, human corneal epithelium and stroma 
constitutively express interleukin-1 receptor antagonist (IL-1 RA), which helps maintain 
corneal immune privilege.(Dana, M. R. et al., 1998; Kennedy et al., 1995) Finally, while 
proinflammatory cytokines contribute to the augmentation of the immune response, 
vascular endothelial growth factor (VEGF) secreted by polymorphonuclear (PMN) cells, and 
local epithelial cells, contributes to corneal neovascularization in HSK.(Lee, S. et al., 2002; 
Zheng, M. et al., 2001)  
Chemokines are specific, small cytokines of 8-10 kDa and can be classified according to their 
structure and function. Structurally, they fall into four families, the two most important of 
which are the CXC (alpha) and CC (beta) families. The CC and CXC chemokines are named 
based on intervening residues between their amino (N)-terminal cysteine amino acids. 
Hence, the CC family of chemokines have two adjacent cysteine amino acids near the N-
terminus without an intervening residue. However, in the CXC family of chemokines, these 
N-terminal cysteine residues are separated by an amino acid “X”, thus their “CXC” 
salutation. Chemokine receptors (CCR) CCR1, CCR2, CCR5, CXC chemokine receptor 
(CXCR) CXCR2 and their ligands (CCL/CXCL) have a well-defined role in HSV. Viral 
replication leads to expression of chemokines such as macrophage inflammatory protein 
(MIP)-1α/CCL3, KC/CXCL1, MIP-1ȕ/CCL4, MIP-2/CXCL2, monocyte chemotactic protein 
(MCP)-1/CCL2 and lymphotactin/XCL1. (Thomas, J. et al., 1998) (Wolpe et al., 1989) Of 
these, MIP-1 α /CCL3 plays the most pivotal role in causing stromal inflammation, possibly 
by recruiting neutrophils and T cells as seen in experimental studies on murine 
corneas.(Tumpey et al., 1998; Wolpe et al., 1988) Furthermore, CXCR3 and its ligands, 
namely, monokine induced by gamma interferon (MIG)/CXCL9, interferon gamma-induced 
protein 10 (IP-10)/CXCL10 and interferon-inducible T-cell alpha chemoattractant (I-TAC)/ 
CXCL11 may also contribute to the development of a protective, anti-viral immune response 
seen in the cornea following HSV-1 infection. (Carr et al., 2008; Wuest & Carr, 2008) These 
chemokines may form potential targets for therapy in HSK.  
It is well established that primary infection with HSV-1 incites both a localized innate 
immune response, and systemic immunity through the adaptive arm of the immune 
cascade. The localized innate immune response involves PMNs, natural killer (NK) cells, 
and macrophages, with the adaptive immune response involving DCs and T cells.(Brandt & 
Salkowski, 1992; Ghiasi et al., 2000; Hendricks & Tumpey, 1990; Meyers-Elliott & Chitjian, 
1981; Niemialtowski & Rouse, 1992a; Pepose, 1991; Tullo et al., 1983; Tumpey et al., 1996) 
Clinically, the collection of these cells is seen as infiltrates in the corneal stroma. Within 48 
hours following infection, PMN cells, which constitute the first line of defense, are recruited 
to the cornea by means of the limbus vasculature, following a multi-step adhesion cascade, 
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including selectins, integrins, and chemokines.(Thomas, J. et al., 1997) A cytokine and 
chemokine response by recruited PMN cells, including tumor necrosis factor (TNF-
α),(Daheshia et al., 1998) then quickly translates into recruitment of other cells to the site of 
infection. Additionally, toll-like receptors (TLRs) expressed on the corneal epithelium and 
stroma, recognise pathogens and their activation leads to generation of both an innate and 
acquired adaptive immune responses. Of particular note are TLRs 3, 4, 7, and 9 which 
mediate an anti-viral response to corneal epithelial infection with HSV-1 (Redfern & 
McDermott) Binding of the pathogen to TLRs causes release of cytokines and chemokines 
which provide alert signals to draw in inflammatory cells such as neutrophils and 
lymphocytes. TLR activation also induces resident corneal APCs to express MHC-II and 
costimulatory molecules thus engaging the acquired immune response.(Hamrah & Dana, 
2007) The anti-viral immune response of TLR7 has been successfully tested in clinical trials 
treating HSV following the success of Imiquimod, an FDA-approved TLR7 agonist used in 
the treatment of infection with the human papilloma virus (HPV).(Miller, R. L. et al., 2008) 
Despite encouraging results of TLR agonist therapy for HSV, one must exercise caution in 
their use since excessive TLR stimulation can lead to an unfavourably strong immune 
response with much damage to bystander cells and tissues of the eye. 
Langerhans cells have been found in abundance near the limbus and are recruited to the site 
of inflammation within a few days in the wake of HSV-1 infection.(Streilein et al., 1979) 
(Asbell & Kamenar, 1987; Hendricks et al., 1992a) There they process the viral antigens for 
presentation to naïve T-helper (Th0) cells in draining lymph nodes. These Th0 cells mature 
into Th1 or Th2 cells depending upon the type of cytokines, prostaglandins and 
costimulatory molecules released by LCs and cells of the innate immune system.(Torres & 
Kijlstra, 2001) The extent of stromal damage in HSK is affected by the density of LCs in the 
cornea.(Asbell & Kamenar, 1987; Hendricks et al., 1992a; Jager et al., 1991; Jager et al., 1992; 
Miller, J. K. et al., 1993) Virally-induced migration or maturation of LCs in the cornea 
precedes the development of HSK. Induction of LC migration into the central cornea before 
HSV-1 infection results in an accelerated and enhanced delayed type hypersensitivity (DTH) 
response to HSV-1 antigens, and an increased severity of HSK. On the contrary, depletion of 
DCs reduces the incidence and severity of HSK, suggesting a role for DCs in the induction 
of a T cell response. These findings have led to the conclusion that HSV-1 infection results in 
de novo migration of LCs from the limbus, which in turn might play a role in the 
immunopathology of HSK through presentation of antigens to T cells in the infected cornea. 
Thus, patients that have a higher density of corneal LCs are likely to get more severe forms 
of HSK, which highlights the role of LCs as a potential therapeutic target in HSK.  
HSK has been studied extensively using mouse models of disease and CD4+ T helper 1 (Th1) 
cells have been purported to be key mediators in the immunopathogenesis of corneal HSV-1 
infection. (Hendricks, 1997; Streilein et al., 1997) In mice depleted of CD4+ cells, HSK 
development and progression was prevented or retarded, whereas depletion of CD8+ cells 
either made no difference or made the severity of HSK worse. (Newell et al., 1989a; Newell 
et al., 1989b) Corticosteroids, which are commonly prescribed in addition to antiviral 
therapy in HSK, work partially via inhibition of CD4+ T-cell response and are thus effective 
in controlling inflammatory damage to the eye. Among other local tissue factors, the kind of 
T-helper response generated is orchestrated by a fine balance between cytokines IL-12 and 
IFN-α, and IL-4 and IL-10, which mature Th0 cells into Th1 or Th2 respectively. (Torres & 
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Kijlstra, 2001) The predominant expression of cytokines IL-2 and IFN- α  in HSK further 
corroborates the role of CD4+ Th1 immune response in HSK pathogenesis.(Hendricks et al., 
1992b; Niemialtowski & Rouse, 1992b) The role of Th2 cells in HSK is far more controversial 
and inconclusive. While some groups state that Th2 cells have negligible involvement in 
HSK, (Niemialtowski & Rouse, 1992a, b) others either ascribe Th2 cells as inducers of HSK, 
(Foster et al., 1993; Jayaraman et al., 1993) or ascribe their role to  convalescent phase of 
HSK.(Jayaraman et al., 1993) There is however one caveat; the kind of response generated is 
also driven by the strain of HSV-1. Corneal infections with the reticuloendotheliosis (RE) 
strain of HSV-1 are predominantly CD4+ driven, whereas the relatively less neuroinvasive 
(KOS) strain recruits and activates CD8+ T cells. (Hendricks & Tumpey, 1990; Newell et al., 
1989a; Russell et al., 1984) T cell mediated delayed type hypersensitivity eventually is critical 
for the elimination of the virus. After this point circulating memory T and B lymphocytes 
continuously scan the cornea. 
The suggested T-cell mediated immune response in HSK, is supported by the fact that 
specific HSV epitopes have been shown to mount an immune response by generation of 
autoreactive T cells. (Zhao et al., 1998) Murine studies of chronic HSK further demonstrated 
that despite clinical signs of active disease and lesions, 10-15 days post viral inoculation, 
viral antigens and messenger RNA (mRNA) were undetectable in the corneas of these 
mice.(Babu et al., 1996) Furthermore, Avery and colleagues performed elegant experiments, 
demonstrating that transfer of autoreactive CD4+ T cells to into athymic mice infected with 
HSV-1, results in the development of HSK.(Avery et al., 1995) However, there is ongoing 
debate regarding the source of antigenic response elicited in HSK. Verjans et al. have shown 
that T cells harvested and cultured from HSK donor corneas failed to show reactivity 
against human corneal antigens.(Verjans et al., 2000) Moreover, human studies to date have 
been inconclusive and it has been hypothesised that a variable clinical spectrum of disease 
in patients with recurrent HSK may either be due to a heterogeneous immune response to 
the HSV epitopes, or, to heterogeneity in the expression of corneal autoantigens in the 
host.(Ellison et al., 2003)  
Based on the ability of HSV-1 to circumvent the immune response and maintain latency, 
along with the complexity of immune players that orchestrate signalling cascades leading to 
a spectrum of disease seen clinically, it is challenging for clinicians to treat HSK effectively. 
Attempts towards immunomodulation of HSK have been made, ranging from induction of 
apoptosis in T cells by amniotic membrane transfer,(Bauer et al., 2009) to suppression of 
chemotaxis and activation of CD4+T cells by targeting chemokine receptors.(Komatsu et al., 
2008; Lee, S. K. et al., 2008). However, with an evolving and deeper understanding of the 
molecular mediators of HSV-1 infection, new molecular targets may provide platforms for 
emerging therapies. 
2.2.2 Pseudomonas keratitis 
One of the most important organisms in the group of bacterial keratitides is the Gram-
negative bacterium Pseudomonas aeruginosa. P. aeruginosa is an opportunistic pathogen, 
which like other microbes, requires a breach in the corneal surface for infection.(Hazlett et 
al., 1978) Such infections are typically seen in individuals who wear contact lenses for 
extended periods of time, and in nosocomial or tropical settings stemming from the ability 
of the bacterium to grow in any niche without much nutritional support.(Hazlett, 2004) 
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Pseudomonal keratitis is highly invasive and can lead to corneal perforation within 24-48 
hours post-infection.(Jones, 1973) Pseudomonal infections of the cornea are marked by 
inflammation and necrosis; there is a suppurative stromal infiltrate, coagulative necrosis, 
epithelial edema, a mucopurulent exudate, and in some cases a paracentral corneal ring 
infiltrate that can be seen in addition to a hypopyon.(Hazlett, 2004) One of the main host 
factors that is the culprit for a stromal meltdown is the massive recruitment of neutrophils, 
which release lysosomal enzymes and oxidative compounds, digesting collagen of the 
stromal extracellular matrix. (Carubelli et al., 1990; Nicas & Iglewski, 1985; Trinkaus-Randall 
et al., 1991; Van Horn et al., 1978; Weiss, 1989) IL-6, one of the cytokines expressed within 24 
hours of P.aeruginosa invasion, may be involved in recruitment of PMNs to the site of 
inflammation by upregulating the expression intercellular adhesion molecule-1 (ICAM-1), a 
key molecule involved in migration of neutrophils.(Cole et al., 1999; Youker et al., 1992) 
Integrin-mediated neutrophil migration is a critical phenomenon that occurs not only within 
the proteoglycan matrix, but also among stromal keratocytes which express adhesion 
molecules.(Burns et al., 2005) 
The rapid spread of infection in the early stages of disease has been attributed in part to a 
delayed response from the responsible TLRs, TLR-2, -4 and -5, which are expressed at a later 
stage in the disease thus leading to a delay in activation of both the innate and adaptive 
arms of the immune response. (Jin et al.) Using a murine model of pseudomonal keratitis, 
Sun and colleagues demonstrated that P.aeruginosa activates expression of TLR-4/5 on 
resident corneal bone marrow-derived macrophages, inducing transcription of chemokines 
and cytokines such as KC/CXCL1, as well as IL-1α and IL-1ȕ. Subsequent recruitment of 
neutrophils into the corneal stroma leads to destruction of P.aeruginosa. The produced IL-1 
has a positive feedback effect by activating the IL-1 receptor in macrophages and other cells 
of the cornea, thus ensuring a sustained response against the bacteria.(Sun et al.) While a 
sustained immune response favours reducing bacterial load, it is also associated with 
bystander local tissue damage from dysregulation of cytokines and chemokines as seen by 
elevated expression of TNF- α , MIP-2/CXCL2, IL-1 but low levels of IL-10.(Zhou et al.) It 
is evident that the role of a prompt and efficient immune response is critical in curtailing the 
spread and severity of pseudomonal keratitis, and eventually in preventing loss of vision. 
However, the caveat to a robust immune response remains the collateral damage incurred to 
surrounding cells and tissues.  
From a therapeutic standpoint, TLRs make interesting molecular targets. Particularly, TLR-9 
is one of the first in its class to be expressed when the cornea is invaded by P. aeruginosa. 
Huang and colleagues used RNA interference (RNAi) to knockdown TLR-9 in mice which 
resulted in decreased corneal opacity, fewer corneal perforations, with decreases in PMNs, 
inductors of the Th1 pathway IFN-Ȗ and IL-12, and mediators of chemotaxis IL-1 ȕ  and 
MIP-2/CXCL2, but higher bacterial titers than controls.(Huang et al., 2005) Further, when 
mice were either depleted of CD4+ T cells or received IFN- Ȗ  neutralising antibodies prior to 
inoculation, they were spared corneal perforation and had a reduced DTH response, 
corroborating the role of a CD4+ T-cell mediated immunopathogenesis of this 
disease.(Kwon & Hazlett, 1997) Cytokines released by CD4+ T cell and LC result in 
infiltration of higher numbers of PMN, eventually leading to increased corneal.(Hazlett et 
al., 2001; Hazlett et al., 2002) While some propose that in order to minimise this collateral 
damage to ocular tissues, therapies should consider directing the immune response from 
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CD4+/Th1 mediated towards a Th2 pathway, (Kijlstra, 1994) others are of the opinion that it 
is the balance between pro-and anti-inflammatory mediators that is of greater significance in 
pseudomonal keratitis. (Hazlett, 2004) (O'Callaghan et al., 1996)  
2.2.3 Fungal keratitis 
Fungal keratitis is a vision-threatening infection and has seen a recent continual rise in 
incidence, with a spike during 2005-2006, following Fusarium contamination of a commercial 
contact lens solution. The three most common risk factors for fungal keratitis are contact 
lens use, trauma and penetrating keratoplasty. (Yildiz et al.) (Iyer et al., 2006) Filamentous 
fungi form the majority of causative organisms with Fusarium (41%), Candida (14%), 
Aspergillus (12%) and Curvularia (12%) being among the top contenders.(Iyer et al., 2006; 
Jurkunas et al., 2009) Fungal infections of the cornea, if not treated immediately and 
managed appropriately, can rapidly lead to corneal ulceration, perforation, corneal 
neovascularisation, loss of vision and possibly, loss of the eye. (Yuan & Wilhelmus, 2009) 
(Thomas, P. A. & Geraldine, 2007) It is thus imperative to understand the molecular 
underpinnings of fungal keratitis, especially the involvement of immune players, for a more 
thorough understanding towards devising novel and efficacious treatment modalities. 
Contact lens wear can compromise the integrity of the corneal epithelium, making it 
susceptible to fungal invasion. It is known that contact lens wear can induce a subclinical 
host immune response with recruitment of LCs into the cornea. (Sankaridurg et al., 2000) 
TLRs on APCs, such as LCs or macrophages, recognize fungi, thereby activating the innate 
and adaptive immune response to clear the infection.(Barton & Medzhitov, 2003; Johnson et 
al., 2005) Hu et al. demonstrated the importance of macrophages through depletion of these 
cells, showing the contribution of macrophages in two different fungal infection models 5 
and 7 days following infection. In this study development of more severe keratomycosis in 
mice depleted of macrophages points the contribution of macrophages in limiting fungal 
disease. (Hu et al., 2009) In vitro studies have shown that inactivated hyphae of Fusarium 
solani upregulate gene expression of TLRs-2, 3, 4 and 6, along with protein expression of 
TLRs 2 and 4 with resultant increases in cytokine expression of IL-6 and IL-8. The 
importance of TLR-4 in modulating the host defense mechanisms to fungi, especially 
Fusarium keratitis, has been demonstrated by several groups. In an experimental model of 
infectious keratitis, it was observed that resolution of Fusarium keratitis involved activation 
of both the innate immune response along with the adaptive arm through TLR-4.(Sun et al.) 
In another murine study, inoculation in knockout models of TLR-4, lead to impaired host 
anti-fungal defense mechanisms, decreased production of CXCL1 with subsequent 
decreased recruitment of neutrophils into the cornea, as well as uncontrolled fungal growth 
and eventually corneal perforation (Tarabishy et al., 2008) On the contrary, hydrocortisone 
treatment in vitro leads to a TLR-mediated increase in resistance to Fusarium solani with a 
concomitant increase in IL-6 expression by human corneal endothelial cells (HCEC).(Jin et 
al., 2007) 
Similarly, in humans, fungal keratitis secondary to Aspergillus and Candida species also rely 
on human corneal TLRs 2 and 4 for hosting an immune response.(Mambula et al., 2002; 
Netea et al., 2002; Netea et al., 2003) TLRs 2 and 4 recognise fungal zymosan and mannan, 
leading to an expected increase in the production of IL-6 and IL-1ȕ when challenged with 
Aspergillus, which is diminished by knocking down these innate receptors, confirming the 
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putative role of TLRs 2 and 4 in Aspergillus keratitis.(Guo & Wu, 2009) In a recent study 
from the same group investigated the effect of targeting TLR2 by a small interfering RNA 
(siRNA) construct applied subconjunctively and topically to the cornea, showed that 
suppressing TLR2 expression in the cornea results in a decrease in neutrophil infiltration, 
allowing the cornea to preserve its morphological integrity. Suppressing TLR2 expression 
also caused a decrease in TNF-α, IL-1ȕ, IL-6, IL-12, monocyte chemoattractant protein (MCP-
1)/CCL2 and macrophage inflammatory protein (MIP-2)/CXCL2 expression. 
Immunomodulation by targeting TLR2 might be a treatment approach in fungal keratitis to 
avoid damage to the cornea by an immune response.(Guo et al.) Aspergillus fumigatus also 
induces IL-10 expression, and taken together, these cytokines attract and direct PMNs into 
the cornea, inciting innate immunity.(Redfern & McDermott) Thus, in addition to anti-
fungal therapy, modulating fungus-specific TLR responses and controlling the host’s 
immune response to the patient’s advantage, is an exciting avenue to explore in the field of 
molecular anti-fungal therapy towards quicker resolution of infection with minimal residual 
damage. 
2.2.4 Acanthamoeba keratitis 
Acanthamoeba keratitis (AK) is a resilient, vision-threatening infection of the cornea. 
Acanthamoeba is an ubiquitous protozoa, which is exceptionally difficult to treat. Infection 
with Acanthamoeba either resolves spontaneously, or, as often seen, results in progressive 
infection and eventual corneal melting, suggesting a role of the immune system in its 
pathophysiology. Corneal transplantation is indicated in cases of severe infection, however, 
reinfection can commonly occur due to the presence of Acanthamoeba cysts within the host 
graft bed. Reinfection and recrudescence indicates the absence of memory against this 
parasite, and hence a poor activation of the adaptive arm of the immune response. 
Acanthamoeba species exist freely in the environment and on certain mucosal surfaces of 
healthy individuals.(Alizadeh et al. 1996; Niederkorn et al. 1999) Two of the most critical 
risk factors for AK include contact lens use and corneal trauma.(Niederkorn et al. 1999) 
Trophozoites attach to the surface of the contact lens which are then introduced to the ocular 
surface. Integrity of the host immune machinery predicts the severity of infection and 
incidence of disease as patients with AK have lower tear levels of IgA against Acanthamoeba 
antigens as compared to healthy controls, implicating the role of mucosa-mediated 
immunity in AK. (Alizadeh et al. 2001) The unique resilience of the double-layered cellulose 
wall of Acanthamoeba cysts, which are resistant to extreme temperatures, UV and gamma 
irradiation, underlies the challenges of treating AK. Systemic immunization to Acanthamoeba 
antigens does not confer immunity unlike mucosa-induced immunity. 
Once the trophozoites invade the corneal epithelium through dislodgement of the epithelial 
cells caused by contact-lens induced microabrasions, there is a TLR-4-mediated immune 
response in corneal epithelial cells with release of cytokines IL-8 and TNF-α as shown in rats 
(Ren and Wu 2011). The innate immune response is activated with recruitment of 
neutrophils and macrophages. Macrophages are believed to be pivotal to the resolution of 
AK. They have a chemotactic response to the pathogen, and bear an inherent ability to kill 
the trophozoites in vivo. This phenomenon can be demonstrated by the depletion of 
macrophages in Clodronate treated animals which develop severe, chronic AK. (Stewart et 
al. 1992; van Klink et al. 1996) Although cysts are more difficult to eradicate, macrophages 
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forming the first line of defence in AK may also attack Acanthamoeba cysts by direct 
phagocytosis as seen in vitro (Hurt et al. 2003). Like macrophages, neutrophils also form the 
first-line defence against both Acanthamoeba cysts and trophozoites, but demonstrate a more 
robust and efficient response. They are found in large numbers in corneas with AK, where 
they clear the protozoan using myeloperoxidase-dependent killing. Neutrophils are 
important both in the prevention and resolution of AK.(Hurt et al. 2003; Clarke et al. 2005).  
The most convincing and potent response from the adaptive arm of the immune system is 
the secretion of IgA antibody. IgA antibody promotes neutrophil-mediated killing of 
trophozoites hence preventing adhesion of the trophozoites to the corneal epithelium. 
Furthermore, it shuts down the corneal melt-down plant of the trophozoites by inhibiting 
mannose-induced cytopathic protein 133 (MIP-133)-induced digestion of the corneal 
epithelium and stroma. The role of corticosteroids in the treatment of AK remains 
controversial. This issue arises from the contrary effects of dexamethasone on the eye; on the 
one hand they help in the resolution of AK-associated ocular inflammation, but on the other 
hand, they induce excystment of dormant cysts leading to recrudescence. Thus, targeting 
MIP-133 offers an attractive target in the therapy of AK. Earlier detection of disease by 
visualization of cysts in the cornea using in vivo confocal microscopy (IVCM) may offer an 
advantage in the management of AK.(Kumar et al. 2010) Through a more sensitive approach 
in the detection and consequent treatment of AK, the prognosis may be improved leading to 
fewer cases of corneal melting and associated complications. 
2.3 Corneal transplantation 
Corneal transplantation is the most common form of solid tissue transplantation with 
approximately 45,000 cases being performed annually in the United States alone.(CCTS, 
1992; Niederkorn, 1999; Streilein, 1999) Unlike other solid tissue transplants, corneal 
allotransplants enjoy immune privilege, and neither require standard human leukocyte 
antigen (HLA) matching, nor permanent systemic immunosuppression. First time recipients 
of corneal allografts enjoy a 2-year graft survival rate of greater than 90% if the recipient 
corneal bed is avascular and free of inflammation.(Niederkorn, 1990) Corneal immune 
privilege is attributed to: (a) an avascular corneal bed which prevents recruitment of 
immune cells and leukocytes to the graft site, thus preventing recognition of non-self HLA 
antigens; (b) lack of lymphatic vessels, which eliminates transport and presentation of non-
self HLA antigens and egress of APCs to T cells in draining lymph nodes, thus decreasing 
sensitisation (c) paucity of mature MHC-II+/HLA-DR+ resident corneal dendritic cells, 
including LC, thus decreasing direct presentation of unmatched HLA antigens to T cells; (d) 
constitutive expression of Fas ligand (CD95; FasL), which programs cell death of activated 
Fas+ T cells; (e) local ocular production of immunomodulatory neuropeptides and factors in 
aqueous humour such as transforming growth factor beta (TGF)-ȕ2 and alpha-melanocyte 
stimulating hormone (α -MSH), which inhibits alloantigen-driven T cell activation and 
DTH.(Dana, M. R. et al., 2000; Dua & Azuara-Blanco, 1999; Griffith et al., 1995; Jager et al., 
1995; Niederkorn, 1990; Niederkorn et al., 1989; Streilein, 1993, 1995; Stuart et al., 1997; Thiel 
et al., 2009) 
Neovascularization of the corneal graft greatly increases the rate of rejection.(Alldredge & 
Krachmer, 1981; Maguire et al., 1994) As per guidelines of the Collaborative Corneal 
Transplantation Studies, the recipient cornea is considered “high-risk” if there is stromal 
www.intechopen.com
 
Advances in Ophthalmology 
 
90
vascularisation in two or more quadrants preoperatively.(1992) The other factors which lead 
to graft rejection include growth of lymphatic vessels into the cornea, thereby establishing 
drainage to the cervical lymph nodes;(Hamrah et al., 2002a) migration of LCs into the 
cornea; maturation of resident LCs and DCs of the cornea, which can then serve as 
APCs;(Dekaris et al., 1999; Hamrah & Dana, 2007; Hamrah et al., 2002b; Liu et al., 2002) 
increased expression of cytokines IL-1 and TNF- α , which lead to recruitment of 
neutrophils, suppression of anterior chamber-associated immune deviation (ACAID), 
maturation of corneal APCs, upregulation of vascular adhesion molecules, and recruitment 
of  leukocytes.(Dana, M. R. & Streilein, 1996; Dana, R., 2007; Hamrah et al., 2007; Pepose et 
al., 1985; Streilein et al., 1996; Yamagami et al., 1999; Zhu, S. et al., 1999; Zhu, S. N. & Dana, 
1999) 
The process of corneal transplant rejection includes an induction phase, called the “afferent” 
arm, and an expression phase, called the “efferent” arm. In the afferent arm, the host 
becomes sensitized to the donor antigens by APCs (e.g., MHC class II-positive DC, LC, 
macrophages, etc.) that present antigens to T cells in draining lymph nodes. This 
sensitization process involves two different pathways. The direct pathway, which involves 
donor APCs that sensitize the host directly when T cells recognize the donor class II MHC, 
thus generating direct alloreactive T cells, and the indirect pathway, which involves host 
APCs that migrate to the graft, take up donor antigens, process it, migrate to draining 
lymph nodes, and then present their antigens to T cells. Host sensitization to donor antigens 
of corneal grafts occurs through both pathways of sensitization, especially in high-risk 
corneal grafting. Further, the critical role of draining cervical lymph nodes in the process of 
allosensitization has been clearly demonstrated by recent studies. Upon arrival in the lymph 
nodes, APCs upregulate surface expression of co-stimulatory molecules, secrete cytokines, 
leading to activation of T cells. The subsequent efferent phase is then responsible for the 
actual rejection of the graft. This phase consists of the proliferation of alloreactive T cells in 
lymphoid organs, migration of these cells to the cornea, and the development of “memory” 
that can assist the alloimmune response in case of repeated exposure to the same antigens. 
Both CD8+ cytotoxic T lymphocyte (CTL) and CD4+ T helper (Th) cells have been implicated 
in the rejection process. Th1 cells uniquely secrete IL-2, IFN-Ȗ, and lymphotoxin, and have 
the purpose of eradicating offending pathogens by promoting inflammation. Th2 cells 
secrete IL-4 and IL-10, suppress Th1 cells, and promote B cell differentiation, leading to the 
production of antibodies. CD4+ Th1 cells are the primary mediators of the efferent arm and 
act directly as effector cells and not as helper cells in corneal graft rejection. IL-2, secreted by 
these cells, stimulates the activation and proliferation of other T and B cells, whereas IFN-Ȗ 
activates macrophages and induces expression of class II antigens in the donor tissue. The 
role of CD8+ T cells in the rejection of allogeneic corneal grafts remains controversial. While 
CD8+ T cells can contribute to graft rejection, corneal grafts can still be rejected in their 
absence, hence making CD8+ T cells sufficient but not necessary for graft rejection.  
A major factor directing the recruitment of T cells and other leukocytes into grafts are 
chemokines. Surgical trauma induces  release of early cytokines such as TNF-α and IL-1 by 
corneal epithelial cells. These cytokines in turn stimulate the production of early neutrophil- 
and macrophage-attractant chemokines, including MIP-2/CXCL2, MCP-1/CCL2, regulated 
upon activation normal T-cell expressed and secreted protein (RANTES)/CCL5, MIP-
1α/CCL3, MIP-1ȕ/CCL4 and eotaxin/CCL11, especially after high-risk corneal 
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transplantation.(Flynn et al., 2008; Yamagami et al., 2005; Yamagami et al., 2000; Yamagami 
et al., 1999) While early chemokines direct non-antigen-specific leukocytes to the graft, late 
chemokines as stated above produced by the graft and infiltrating leukocytes recruit 
alloantigen-primed T cells into the graft. In addition, recipients of high-risk transplants 
express very high levels of the IP-10/CXCL10 chemokine. Chemokines function together 
with other molecular mediators including integrins and adhesion molecules to direct the 
immune response toward the graft. Therapeutic endeavours seek to inhibit either or both 
arms of the immune response to prolong graft survival. Regulatory T cells (Foxp3+Tregs) 
have been shown to promote graft survival by inhibiting alloimmunity in draining lymph 
nodes as opposed to altering to the effector arm of the immune response.(Chauhan et al., 
2009; Cunnusamy et al.; Tang & Bluestone, 2008)  Measures devised to enhance graft 
survival should essentially revolve around three main goals: (a) to prevent induction of 
alloimmune response, (b) to inhibit or deplete immune effector cells, and, (c) to induce 
tolerance to specific alloantigens.(Niederkorn, 2002)  
2.4 Dry Eye Disease 
Dry eye disease (DED) is one of the most common diagnoses made in ophthalmic practice. 
DED affects millions of people around the world. It is more prevalent in women than men and 
is of inflammatory etiology.(Calonge et al.; 2007b) In epidemiologic studies conducted by 
Schaumberg and colleagues, they found a prevalence of 5.7% in women aged 50 years or 
younger, and 9.8% in women aged 75 years or above.(Schaumberg et al., 2003) Patients usually 
present with ocular irritation and in severe cases, there may be accompanying ocular pain, 
punctate keratopathy and filamentary keratitis.(Pflugfelder, 1998) The definition of DED has 
been modified over the years to integrate evolving concepts of the involvement of tear film 
hyperosmolarity, inflammation of the ocular surface, and the effects of DED on vision. In 2007, 
the International Dry Eye Workshop (DEWS) defined DED as: “a multifactorial disease of the 
tears and ocular surface that results in symptoms of discomfort, visual disturbance, and tear 
film instability with potential damage to the ocular surface. It is accompanied by increased 
osmolarity of the tear film and inflammation of the ocular surface.”(DEWS, 2007a)  
Clinically, DED can be categorised into (a) aqueous deficient and, (b) evaporative dry eye. 
(Lemp, 1995) Aqueous deficient DED consists of disorders that affect the lacrimal functional 
unit (LFU). The term “lacrimal functional unit” was coined in 1998 by Stern and group, 
comprising the ocular surface, lacrimal glands, associated innervation, and neuroendocrine 
factors.(Stern et al., 1998; Stern et al., 2004) The clinical diagnosis of DED is made using a 
combination of examination techniques, including Schirmer’s test, tear film osmolarity, and 
fluorescein tear break-up time (fTBUT). A reading of less than 15mm on the Schirmer’s strip 
in conjunction with elevated tear film osmolarity (>315 mOsm) is indicative of decreased 
tear production, hence, suggestive of aqueous-deficient DED. When fTBUT is less than 10 
seconds, there is increased suspicion of evaporative DED. Diseases that lead to aqueous 
deficient dry eye disease include Sjögren’s syndrome and non-Sjögren’s autoimmune 
conditions. Whereas, evaporative dry eye is due to diseases that affect the production, 
quality and distribution of the tear film lipid layer, namely, meibomian gland dysfunction 
(MGD) and chronic blepharitis.(Barabino & Dana, 2007; Calonge et al.) It has been 
demonstrated that regardless of the etiology of dry eye, inflammation of the ocular surface 
and homing of immune cells to the target tissue, are hallmarks of DED. These immuno-
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inflammatory processes are culprits of corneal and conjunctival damage leading to the 
presenting symptoms.(Barabino & Dana, 2007; Dana, M. R. & Hamrah, 2002) 
Recent evidence suggests a role for chemokines in the pathogenesis of dry eye syndromes. 
Increased RNA levels of IL-8, which is chemotactic for neutrophils, are found in the conjunctival 
epithelium of Sjogren's syndrome patients compared to controls. Furthermore, increased levels 
of select chemokines in the lacrimal glands of nonobese diabetic (NOD) mice, an animal model 
of Sjogren's syndrome, have been detected. NOD mice are a murine model for type-1 insulin-
dependent diabetes with an autoimmune component. They represent a murine model of 
Sjogren’s syndrome based on the similar histopathological picture of sialoadenitis. These mice 
have lymphocytic infiltration of not just the pancreas but also the submandibular and lacrimal 
glands. Both RANTES/CCL5 and IP-10/CXCL10 gene transcripts are detected in lacrimal 
glands at 8 weeks of age increased markedly during the course of active disease, concomitant 
with induction of their receptors CCR1, CCR5 and CXCR3. The examination of lacrimal glands 
indicated that lymphocytes in the inflammatory infiltrates are responsible for the production of 
these chemokines. Moreover, anti-RANTES treatment significantly reduced inflammation in the 
lacrimal glands of these mice. Further, patients with DED have a significant increase in the 
number of ocular surface cells that express CCR5, the receptor for RANTES/CCL5 and MIP-
1ȕ/CCL4. These data suggest that a better understanding of the role of chemokines and 
chemokine receptors in DES could open new doors for development of molecular strategies for 
immune modulation in this common disorder.  
Numerous studies have demonstrated the enhanced expression of pro-inflammatory 
cytokines (e.g., IL-1, IL-6, IL-8, TNF-α ) mRNA and protein by the ocular surface epithelium 
or tear film. The increase of these proinflammatory cytokines can lead to epithelial cell 
proliferation, keratinization, and angiogenesis, and thereby could link ocular surface disease 
with a number of lid margin disorders, such as rosacea, characterized by inflammation. In 
addition, IL-1 may lead to upregulation of matrix proteases, including collagenases, and 
thereby exacerbate stromal pathology as well as alter the paracrine effect of other cytokines 
on resident DCs, macrophages, fibroblasts, and epithelial cells by altering the matrix milieu 
in which these cytokines bind their respective receptors. Corneal epithelial cells respond to 
stress signals by producing cytokine mediators of inflammation such as TNF- α , IL-1ȕ, IL- 8 
and MMPs.(Li et al., 2006; Luo et al., 2004) Subsequently, maturing resident and recruited 
DC carry antigen to the draining lymph nodes to present and activate T cells. T cell-
mediated responses have recently been shown to play a center stage in DED. Th1 cells 
recognize antigenic peptides in association with MHC class II molecules on the surface of 
APC, and release pro-inflammatory cytokines that increase vascular permeability and 
recruit further inflammatory cells to the site of injury. Due to the nonspecific nature of cell 
recruitment employed by CD4+ Th1 cells, inflammation can be severe with damage to 
bystander tissue. More recently, Th 17 associated cytokines and IL 17 producing cells have 
been found in the ocular surface epithelium of dry eye patients and it has been hypothesized 
that epithelial cells subjected to desiccating conditions promote DC to secrete IL-6, IL-23 and 
TGF-ȕ, which in turn induce Th17 cells.(Zheng, X. et al.) 
3. Leukocyte trafficking 
Trafficking signals finely control the movement of distinct subsets of immune cells into and 
out of specific tissues. Leukocyte extravasation from blood to tissue, including that of APC 
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and T cells, usually occurs through a multistep process, involving adhesion molecules and 
chemokines. Because the accumulation of leukocytes in tissues contributes to a wide variety 
of diseases, these 'molecular codes' provide new targets for inhibiting tissue-specific 
inflammation. However, immune cell migration is also critically important for the delivery 
of protective immune responses to tissues. Therefore, the challenge lies in identifying 
trafficking molecules that will specifically inhibit key cell subsets that drive disease 
processes without affecting the migration of leukocytes required for protective immunity.  
Adhesion molecules can be categorized according to their structure or function. Four major 
families are distinguished structurally: the selectins, the sialomucins, the integrins, and the 
Ig superfamily. Leukocyte tethering and rolling, mediated typically by three selectins, L-
selectin, E-selectin and P-selectin, are the first steps in the process of leukocyte binding to 
vascular endothelium. Two selectins, P- and E-selectin, are expressed on activated 
endothelium, whereas L-selectin is found on leukocytes. L-selectin is involved in the 
homing of T cells to lymphoid tissues but is also expressed on other leukocytes, where it 
participates in inflammation. E-selectin is expressed on corneal vascular endothelium, 
whereas P-selectin is expressed on inflamed vascular endothelium and by certain 
leukocytes. P-selectin glycoprotein ligand-1 (PSGL-1) binds all three selectins and is 
expressed on peripheral blood DC.  
In the cornea, studies in both human and animal models of disease have confirmed that cell 
adhesion molecules are closely associated with the development of herpetic keratitis, and 
corneal allograft rejection. P- and E-selectin have been shown to mediate neutrophil 
recruitment to the cornea in studies using P/E-selectin knockout mice. Integrins are found 
on most cell types. Two subfamilies are most important for leukocyte migration: the α4 
(CD49) and the 2 (CD11/CD18) integrins. Four distinct members of 2 integrins exist, three 
of which are expressed by DC. Vascular endothelial ligands for these molecules are 
members of the immunoglobulin superfamily. Leukocyte arrest in venules requires in situ 
activation of at least one of the four main integrins: VLA-4 (binds to VCAM-1), 47 (binds 
to MadCAM-1), Mac-1(binds to ICAM-1) and LFA-1 (binds to ICAM-1 and 2). VCAM-1 has 
been shown to be present on monocytes and vascular endothelial cells during corneal 
inflammation. Arguably the most important ligand for 2 integrins is ICAM-1, which is 
expressed on many cell types and is strongly upregulated upon exposure to inflammatory 
cytokines in the cornea and on limbal endothelial cells, deletion of which has been shown to 
suppress corneal graft rejection.  
Chemokine receptors regulate leukocyte retention within tissues. The migration of 
leukocytes to inflammatory sites depends on a cascade of discrete events mediated, in part, 
by chemokines and their receptors. Numerous chemokines have now been described during 
inflammation, including CCL3/MIP-1, CCL4/MIP-1, and CCL5/RANTES, ligands for 
CCR1 and CCR5; CCL2/MCP-1, a ligand for CCR2; CCL22/MDC and CCL17/TARC, 
ligands for CCR4; CCL20/MIP-3α, the ligand for CCR6; CXCL8/IL-8, a ligand for CXCR1 
and CXCR2; CXCL1/KC, CXCL2/MIP-2, and CXCL5/ENA-78, ligands for CXCR2; CXCL9 
/MIG, CXCL10/IP10 and CXCL11/ITAC, ligands for CXCR3. In addition, constitutively 
expression of CCLs 2-5,CXCL10, and CCL27/CTACK, a ligand for CCR10 have been 
described in the normal cornea. Which of these chemokines is relevant in recruitment, 
retention and egrees of corneal APC, is unclear. Little is known about the constitutive 
recruitment of DC and macrophage precursors into peripheral tissues in the absence of 
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inflammation. APC function and migratory behavior are related to rapid and coordinated 
switching in chemokine receptor expression by these cells, allowing them to coordinate 
migratory routes and biological function. During inflammation, CCL2, CCL5, and CXCL8 
are produced to attract immature DC that express CXCR4 and CCR4 respectively. In 
addition, these DC are ideally suited for recruitment to inflammatory sites by their 
expression of functional receptors for inflammation-induced chemokines, such as CCR1, 
CCR2, CCR3, CCR5 and CXCR1.  
Inflammatory signals induce resident corneal DCs to undergo maturation. Upon 
maturation, DCs downregulate pattern recognition receptors necessary for surveillance of 
antigens  and upregulate CCR7, a receptor important in the homing of DCs to the lymph 
nodes. Maturing CCR7+ DCs then enter CCL21-expressing lymphatic vessels and travel to 
the draining lymph nodes where CCR7 ligands, namely, CCL19/EBI1 ligand chemokine 
(ELC) and CCL21/secondary lymphoid tissue chemokine (SLC), are produced. In addition, 
after fluorescein isothiocyanate (FITC) painting (dendritic cell migration assay), CXCR4 
inhibition has been shown to impair LC and dermal DC migration to draining LNs, 
indicating that both CCR7 and CXCR4 make independent contributions to the egress of DCs 
from resident tissue to the lymph nodes. DC migration into and along afferent lymphatics 
occurs through a series of steps, including (1) mobilization, (2) detachment, (3) interstitial 
migration, (4) entry into the afferent lymphatics, and (5) transit via lymph. Recent data have 
shown that lymphatic endothelial cells upregulate E-selectin, chemokines (CCL5, CCL20, 
and CXCL5), and adhesion molecules (ICAM-1 and VCAM-1) after cytokine stimulation in 
vitro or in vivo. Once in the draining lymph nodes, antigen-loaded mature DCs activate 
naive T cells, which then proliferate and enter the blood and migrate back to the site of 
inflammation. In the cornea, CCR5 and CX3CR1, but not CCR1 are partially involved in the 
recruitment of MHC-II+ LCs. How the central immature LC or stromal APC populations are 
recruited is not known, although the recently demonstrated constitutive expression of CCR2 
on stromal BM-derived cell subsets, implicates a role for this chemokine. Further, both 
vascular endothelial growth factor (VEGFR)-3 and CCR7 are partially implicated in the 
egress of stromal DCs. APC recruitment to the cornea is likely complex, highly regulated 
and dependent on recruitment signals that are either tissue-specific or inflammation-
induced, or both.  
4. Conclusion 
The cornea and ocular surface are constantly exposed to environmental pollutants and 
irritants, microbes, and other potentially noxious agents. Since from an evolutionary 
standpoint the scope of the host defense mechanisms against these stimuli should be 
narrow, that is to say adequately effective to protect the eye against the potential harm from 
these agents and yet tempered enough not to lead to unwanted damage, the eye has 
developed many mechanisms to effect and regulate its response to environmental 
challenges. Identification of the critical pathways of cell migration to and from the cornea 
will provide new molecular targets for pharmacological intervention in inflammatory, 
infectious, alloimmune and autoimmune diseases and may lead to novel highly specific 
strategies for immunotherapy, through modulation of APC and T cell migration and 
function. Few effective anti-inflammatory drugs have emerged over the last decades in the 
ophthalmic field and an urgent need for new drugs exists, as many inflammatory diseases 
are inadequately responsive to current medications.  
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